Published in Antimicrob Agents Chemother on May 01, 1987
Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents. Antimicrob Agents Chemother (1989) 1.51
Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Antimicrob Agents Chemother (1990) 1.25
Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do. Antimicrob Agents Chemother (1990) 1.16
Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems. Antimicrob Agents Chemother (1990) 1.14
Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc Natl Acad Sci U S A (1989) 0.99
In vitro assays used to measure the activity of topoisomerases. Antimicrob Agents Chemother (1990) 0.98
No cytogenetic effects of quinolone treatment in humans. Antimicrob Agents Chemother (1988) 0.93
Modification of immune response in mice by ciprofloxacin. Antimicrob Agents Chemother (1995) 0.88
Limited effects of temafloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob Agents Chemother (1994) 0.88
Influence of two quinolones, ofloxacin and pefloxacin, on human myelopoiesis in vitro. Antimicrob Agents Chemother (1989) 0.85
Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C. Curr Microbiol (2012) 0.82
CP-115,953 stimulates cytokine production by lymphocytes. Antimicrob Agents Chemother (1995) 0.82
Biphasic response of ciprofloxacin in human fibroblast cell cultures. Nonlinearity Biol Toxicol Med (2003) 0.82
Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors. Curr Ther Res Clin Exp (2014) 0.79
Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A (1977) 14.75
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother (1986) 6.20
Biology of bacterial deoxyribonucleic acid topoisomerases. Microbiol Rev (1984) 5.10
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65
Mutational resistance to 4-quinolone antibacterial agents. Eur J Clin Microbiol (1984) 3.22
Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci U S A (1985) 3.18
Investigations into the mechanism of action of the antibacterial agent norfloxacin. J Antimicrob Chemother (1984) 2.71
Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J Biol Chem (1971) 2.36
Gene amplification in a single cell cycle in Chinese hamster ovary cells. J Biol Chem (1984) 2.32
Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids. Antimicrob Agents Chemother (1986) 2.08
Banding in human chromosomes treated with trypsin. Nat New Biol (1972) 2.03
Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother (1986) 1.83
N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J Biol Chem (1974) 1.81
Targeted and untargeted mutagenesis by various inducers of SOS functions in Escherichia coli. Cold Spring Harb Symp Quant Biol (1979) 1.74
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother (1984) 1.47
Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother (1986) 1.24
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis (1985) 1.16
Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase. Biochem Biophys Res Commun (1984) 1.14
Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. Nature (1983) 1.12
Mitochondria contain a distinct DNA topoisomerase. J Biol Chem (1979) 1.05
Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerases. Carcinogenesis (1985) 1.02
Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate. Cancer Res (1979) 0.89
Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid. Biochem Pharmacol (1981) 0.84
DNA-protein cross-linking by ultraviolet radiation in normal human and xeroderma pigmentosum fibroblasts. Biochim Biophys Acta (1976) 0.84
Increase of uv-induced DNA repair synthesis during blast transformation of human lymphocytes. Exp Cell Res (1979) 0.84
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 24.32
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A (1980) 11.23
Monoclonal antibodies defining distinctive human T cell surface antigens. Science (1979) 10.50
Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 10.28
Penicillin-binding proteins and cell shape in E. coli. Nature (1975) 10.20
"Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol (1966) 9.65
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med (1983) 9.23
A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A (1974) 8.74
An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell (1984) 7.56
A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol (1980) 6.96
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
Specific purification of lymphocyte populations on a digestible immunoabsorbent. J Immunol (1973) 6.64
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell (1984) 6.53
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol (1980) 6.05
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85
Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res (1993) 5.82
Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76
The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci U S A (1988) 5.75
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol (1979) 5.63
Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol (1974) 5.50
The isolation and characterization of the human helper inducer T cell subset. J Immunol (1985) 5.21
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med (1979) 5.19
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity (1994) 5.06
Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature (1983) 4.96
Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell (1982) 4.86
Animal cell cycle. Annu Rev Biochem (1978) 4.80
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med (1980) 4.80
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A (1984) 4.78
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol (1976) 4.65
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A (1996) 4.64
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol (1978) 4.33
Membrane transport proteins. Proteins that appear to be parts of membrane transport systems are being isolated and characterized. Science (1968) 4.23
Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med (1998) 4.16
Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med (1983) 4.10
Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A (1976) 4.05
Cytidine triphosphate synthetase of Escherichia coli B. I. Purification and kinetics. J Biol Chem (1967) 4.01
Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells. Proc Natl Acad Sci U S A (1969) 3.98
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med (1995) 3.83
Changes of membrane proteins and their relation to deoxyribonucleic acid synthesis and cell division of Escherichia coli. J Biol Chem (1970) 3.76
Multiple pathways of putrescine biosynthesis in Escherichia coli. J Biol Chem (1966) 3.74
Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64
The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol (1980) 3.49
Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. J Bacteriol (1975) 3.49
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (1995) 3.46
Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol (1995) 3.39
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
A monoclonal antibody blocking human T cell function. Eur J Immunol (1980) 3.33
Model for regulation of Escherichia coli DNA repair functions. Proc Natl Acad Sci U S A (1975) 3.32
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res (1991) 3.24
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med (1987) 3.14
Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol (1976) 3.13
Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res (1992) 3.12
Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci U S A (1980) 3.12
Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med (1979) 3.10
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. Cell (1983) 3.07
Transport of amino acids by confluent and nonconfluent 3T3 and polyoma virus-transformed 3T3 cells growing on glass cover slips. J Biol Chem (1969) 3.05
Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol (1991) 3.05
A binding site for sulfate and its relation to sulfate transport into Salmonella typhimurium. J Biol Chem (1966) 3.04
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol (1994) 3.02
Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. Proc Natl Acad Sci U S A (1983) 2.93
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92
Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science (1986) 2.89
Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol (1981) 2.86
Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A (1993) 2.85
Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells. Cell (1979) 2.84
The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A (1989) 2.80
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74
A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med (1988) 2.74
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A (1984) 2.71
Purification and properties of a sulfate-binding protein from Salmonella typhimurium. J Biol Chem (1966) 2.69
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med (1989) 2.69
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity (1995) 2.69
Conditional mutations involving septum formation in Escherichia coli. J Bacteriol (1967) 2.64
Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. J Immunol (1979) 2.63
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol (1982) 2.60
Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol (1968) 2.54
Prevalence of nine different micro-organisms in the female genital tract. A comparison between women from a venereal disease clinic and from a health control department. Br J Vener Dis (1979) 2.52
Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science (1982) 2.52
Photoproduct frequency is not the major determinant of UV base substitution hot spots or cold spots in human cells. Proc Natl Acad Sci U S A (1987) 2.50
Stages of B cell differentiation in human lymphoid tissue. J Exp Med (1981) 2.49
Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med (1979) 2.48
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science (1998) 2.46
Characterization of an antigen expressed by human natural killer cells. J Immunol (1983) 2.44
Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol (1967) 2.41
Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science (1993) 2.40
Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes. Nature (1981) 2.39
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol (1985) 2.37